SCHEMBL28983512

SCHEMBL28983512

CC(C)(C)OC(=O)N1CCC(Oc2cc(C(=O)O)c(N)cc2Br)CC1

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.48
▸ PDE4B Q07343 3/20 0.46
▸ PDE4D Q08499 3/20 0.46
▸ PDE4A P27815 2/20 0.46
▸ PDE4C Q08493 2/20 0.46
▸ GPR119 Q8TDV5 8/20 0.46
▸ TOP2A P11388 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ IKBKB O14920 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28983485 0.90 GPR119 (0.50) KDM1APDE4BPDE4DPDE4APDE4C
SCHEMBL1446669 0.88 KDM1A (0.48) KDM1APDE4BPDE4DPDE4APDE4C
SCHEMBL28983500 0.87 GPR119 (0.46) KDM1APDE4BPDE4DPDE4APDE4C
SCHEMBL7364955 0.86 PDE4B (0.54) KDM1APDE4BPDE4DPDE4APDE4C
SCHEMBL15363254 0.85 KDM1A (0.48) KDM1APDE4BPDE4DPDE4APDE4C
SCHEMBL28983510 0.83 GPR119 (0.45) KDM1APDE4BPDE4DPDE4APDE4C
SCHEMBL25318077 0.83 PDE4B (0.47) KDM1APDE4BPDE4DPDE4APDE4C
SCHEMBL30986535 0.83 PDE4B (0.47) KDM1APDE4BPDE4DPDE4APDE4C
SCHEMBL5971118 0.81 PDE4B (0.53) KDM1APDE4BPDE4DPDE4APDE4C
SCHEMBL28779854 0.81 IKBKB (0.47) PDE4BIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115803326-B EGFR inhibitor, preparation method thereof and application thereof in pharmacy 上海和誉生物医药科技有限公司 2024-03-26 — — CN disclosed
CN-115803326-A EGFR inhibitor, preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2023-03-14 — — CN disclosed
WO-2022105908-A1 EGFR INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 上海和誉生物医药科技有限公司 2022-05-27 — — WO disclosed
Send feedback